Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(9):754; doi:10.1093/jnci/92.9.754
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Brodsky, R. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Brodsky, R. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 9, 754, May 3, 2000
© 2000 Oxford University Press

BOOK REVIEW

Aplastic Anemia: Pathophysiology and Treatment

H. Schrezenmeier, A. Bacigalupo, eds. Cambridge (U.K.): Cambridge University Press, 2000. 391 pp., illus., $110. ISBN 0-521-64101-2

Robert A. Brodsky

Correspondence to: Robert A. Brodsky, M.D., Department of Oncology, Division of Immunology and Hematopoiesis, The Johns Hopkins Oncology Center, Cancer Research Bldg., Rm. 242, 1650 Orleans St., Baltimore, MD 21231 (e-mail: rbrodsky@jhmi.edu).

Aplastic anemia is a rare hematopoietic disease with an incidence of two to six new cases per million people in the United States. For decades, the disease has fascinated clinicians and researchers in diverse fields, including hematologists, stem cell biologists, immunologists, and hematopoietic stem cell transplanters. This intense study of aplastic . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?